Clinical Trial Update: EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 trial of early interferon beta-1a in combination with simvastatin for Clinically Isolated Syndrome suggestive of Multiple Sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Multiple Sclerosis

Drugs mentioned

• Interferon beta-1a (Interferon beta-1a)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of North Carolina | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED